home / stock / cing / cing news

CING News and Press, Cingulate Inc. From 02/02/24

Stock Information
Company Name: Cingulate Inc.
Stock Symbol: CING
Market: NASDAQ
Website: cingulate.com
Menu
CING CING Quote CING Short CING News CING Articles CING Message Board
Get CING Alerts

News, Short Squeeze, Breakout and More Instantly...
CING - Cingulate Announces Pricing of $7.5 Million Public Offering

KANSAS CITY, Kan., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR&#x...
CING - BFRI and CING among pre-market losers

2024-02-02 08:21:14 ET More on pre-market losers & stocks etc. Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alphaȁ...

CING - Cingulate promotes Jennifer Callahan to CFO

2024-01-29 08:24:01 ET More on Cingulate New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alpha’s Quant Rating on Cingulate Historical earnings data for Cingulate Financ...

CING - Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical ...
CING - Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical p...

CING - New ADHD drugs could pay off for pharmaceutical companies

2024-01-21 13:30:00 ET Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for improved drugs in the space. Currently, the medications of choice for the condition are stimulant drugs, such as Takeda's ( NYSE: TAK ) V...

CING - Cingulate files to sell common stock and warrants

2024-01-15 00:48:17 ET More on Cingulate Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alpha’s Quant Rating on Cingulate Historical earnings data for Cingulate Financial information for Cingulate For further details see: ...
CING - Low Float Stocks Ready to Fill the Gap

2024-01-10 07:23:53 ET DENVER, Colo, January 10, 2024 ( www.247marketnews.com ) – A quick peek at some of our favorite low-float listings clearly shows that our top trend for 2023 has only been stronger in 2024, with many of them delivering even bigger gains to open the year. Siy...

CING - 2 for 2- 24/7 Market News Wrap 3 Jan 2024

2024-01-03 19:51:02 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ: ABVC), Neximmune Inc (NASDAQ: NEXI), Sidus Space Inc (NASDAQ: SIDU), Voyager Therapeutics Inc (NASDAQ: VYGR), and Cingulate...

CING - SXTC, CGA and JFBR among pre-market losers

2024-01-02 08:30:21 ET Losers: Corcept Therapeutics CORT -33% in patent battle with Teva . China SXT Pharmaceuticals ( SXTC ) -29% . Sentage Holdings ( SNTG ) -27% . China Green Agriculture ( CGA ) -23% . Aditxt ( ADTX ) -24% . ...
Previous 10 Next 10